Home > Boards > US Listed > Biotechs > Agile Therapeutics, Inc. (AGRX)

It was looking good After Hours. It hit

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
RealPainkiller Member Profile
 
Followed By 9
Posts 1,576
Boards Moderated 0
Alias Born 03/30/20
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 1/14/2021 8:31:36 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/11/2021 6:31:27 AM
Agile Therapeutics to Participate in Fireside Chat at the H.C. Wainwright BIOCONNECT 2021 Virtual Conference GlobeNewswire Inc. - 1/4/2021 12:18:15 PM
Agile Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference GlobeNewswire Inc. - 12/21/2020 7:30:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/7/2020 4:31:05 PM
Agile Therapeutics Announces Nationwide Commercial Launch and Availability of Twirla® (levonorgestrel and ethinyl estradiol)... GlobeNewswire Inc. - 12/7/2020 7:30:00 AM
Agile Therapeutics Announces Peer-Reviewed Publication of Phase 3 SECURE Study Results for Twirla® (levonorgestrel and ethin... GlobeNewswire Inc. - 11/30/2020 9:11:25 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/23/2020 5:01:26 PM
Amended Statement of Beneficial Ownership (3/a) Edgar (US Regulatory) - 11/23/2020 4:46:36 PM
Agile Therapeutics to Participate in the 32nd Annual Piper Sandler Healthcare Conference GlobeNewswire Inc. - 11/23/2020 10:00:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/12/2020 4:17:20 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/12/2020 4:11:23 PM
Agile Therapeutics Reports Third Quarter 2020 Financial Results GlobeNewswire Inc. - 11/12/2020 4:05:00 PM
Agile Therapeutics to Host Third Quarter 2020 Financial Results Conference Call and Provide Corporate and Twirla® Commercial... GlobeNewswire Inc. - 11/4/2020 7:30:00 AM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 10/15/2020 6:30:17 AM
Securities Registration Statement (simplified Form) (s-3) Edgar (US Regulatory) - 10/2/2020 4:32:08 PM
Amended Statement of Beneficial Ownership (sc 13d/a) Edgar (US Regulatory) - 10/1/2020 4:26:17 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/28/2020 4:11:13 PM
Agile Therapeutics to Present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit GlobeNewswire Inc. - 9/22/2020 11:40:25 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/21/2020 4:10:58 PM
Agile Therapeutics to Participate in Fireside Chat at the H.C. Wainwright 22nd Annual Global Investment Virtual Conference GlobeNewswire Inc. - 9/9/2020 8:00:10 AM
Agile Therapeutics Announces Virtual Investor/Analyst Day on Monday, September 21, 2020 GlobeNewswire Inc. - 9/8/2020 8:00:10 AM
Agile Therapeutics Launches I’m So Done Campaign to Inspire Women to Take an Active Role in Choosing their Birth Control GlobeNewswire Inc. - 9/2/2020 9:00:10 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/26/2020 5:00:53 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/20/2020 4:16:35 PM
RealPainkiller   Saturday, 05/02/20 10:43:36 AM
Re: mellow fellow post# 1005
Post # of 1056 
It was looking good After Hours. It hit $3.00 easily. Pre-market on Monday should look good.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
© 2021 InvestorsHub.com, Inc.
Consent Preferences